img

Global and United States Losartan Potassium and Hydrochlorothiazide Tablet Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Losartan Potassium and Hydrochlorothiazide Tablet Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Losartan Potassium and Hydrochlorothiazide Tablet Market
This report focuses on global and United States Losartan Potassium and Hydrochlorothiazide Tablet market, also covers the segmentation data of other regions in regional level and county level.
The global Losartan Potassium and Hydrochlorothiazide Tablet revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Losartan Potassium and Hydrochlorothiazide Tablet revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Losartan Potassium and Hydrochlorothiazide Tablet include Cozaar, Lepu Medical Technology (Beijing), Zhejiang NuoDe Pharmaceutical, Dawnrays Pharmaceutical, TIANJIN PHARMACEUTICAL DA REN TANG GROUP, Beijing Winsunny Pharmaceutical, Shandong XinYi Pharmaceutical, Zhejiang Huahai Pharmaceutical and Beijing Twinluck, etc. The global five biggest players hold a share of % in 2024.
Global Losartan Potassium and Hydrochlorothiazide Tablet Scope and Market Size
Losartan Potassium and Hydrochlorothiazide Tablet market is segmented in regional and country, by players, by potassium content of losartan per tablet and by application. Companies, stakeholders, and other participants in the global Losartan Potassium and Hydrochlorothiazide Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by potassium content of losartan per tablet and by application for the period 2018-2034.
For United States market, this report focuses on the Losartan Potassium and Hydrochlorothiazide Tablet market size by players, by Potassium Content of Losartan Per Tablet and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Cozaar
Lepu Medical Technology (Beijing)
Zhejiang NuoDe Pharmaceutical
Dawnrays Pharmaceutical
TIANJIN PHARMACEUTICAL DA REN TANG GROUP
Beijing Winsunny Pharmaceutical
Shandong XinYi Pharmaceutical
Zhejiang Huahai Pharmaceutical
Beijing Twinluck
Segment by Potassium Content of Losartan Per Tablet
50mg
100mg
Others

Segment by Application


Children
Adult
Elderly
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Losartan Potassium and Hydrochlorothiazide Tablet definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by potassium content of losartan per tablet, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Losartan Potassium and Hydrochlorothiazide Tablet companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Losartan Potassium and Hydrochlorothiazide Tablet in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by potassium content of losartan per tablet, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by potassium content of losartan per tablet, by application and by region, sales, and revenue for each segment.
Chapter 8China by potassium content of losartan per tablet, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by potassium content of losartan per tablet, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Losartan Potassium and Hydrochlorothiazide Tablet sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Losartan Potassium and Hydrochlorothiazide Tablet Product Introduction
1.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Outlook 2018 VS 2024 VS 2034
1.2.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in US$ Million for the Year 2018-2034
1.2.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume for the Year 2018-2034
1.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Outlook 2018 VS 2024 VS 2034
1.3.1 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in US$ Million for the Year 2018-2034
1.3.2 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume for the Year 2018-2034
1.4 Losartan Potassium and Hydrochlorothiazide Tablet Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Losartan Potassium and Hydrochlorothiazide Tablet in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Losartan Potassium and Hydrochlorothiazide Tablet Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Losartan Potassium and Hydrochlorothiazide Tablet Market Dynamics
1.5.1 Losartan Potassium and Hydrochlorothiazide Tablet Industry Trends
1.5.2 Losartan Potassium and Hydrochlorothiazide Tablet Market Drivers
1.5.3 Losartan Potassium and Hydrochlorothiazide Tablet Market Challenges
1.5.4 Losartan Potassium and Hydrochlorothiazide Tablet Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Losartan Potassium and Hydrochlorothiazide Tablet by Potassium Content of Losartan Per Tablet
2.1 Losartan Potassium and Hydrochlorothiazide Tablet Market Segment by Potassium Content of Losartan Per Tablet
2.1.1 50mg
2.1.2 100mg
2.1.3 Others
2.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Potassium Content of Losartan Per Tablet
2.2.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
2.2.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
2.2.3 Global Losartan Potassium and Hydrochlorothiazide Tablet Average Selling Price (ASP) by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
2.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Potassium Content of Losartan Per Tablet
2.3.1 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
2.3.2 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
2.3.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Average Selling Price (ASP) by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
3 Losartan Potassium and Hydrochlorothiazide Tablet by Application
3.1 Losartan Potassium and Hydrochlorothiazide Tablet Market Segment by Application
3.1.1 Children
3.1.2 Adult
3.1.3 Elderly
3.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Application
3.2.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Losartan Potassium and Hydrochlorothiazide Tablet Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Application
3.3.1 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Losartan Potassium and Hydrochlorothiazide Tablet Competitor Landscape by Company
4.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Company
4.1.1 Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Ranked by Revenue (2024)
4.1.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Revenue by Manufacturer (2018-2023)
4.1.3 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales by Manufacturer (2018-2023)
4.1.4 Global Losartan Potassium and Hydrochlorothiazide Tablet Price by Manufacturer (2018-2023)
4.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Concentration Ratio (CR)
4.2.1 Losartan Potassium and Hydrochlorothiazide Tablet Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet in 2024
4.2.3 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Product Offered and Application
4.5 Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Company
4.7.1 Key Players of Losartan Potassium and Hydrochlorothiazide Tablet in United States, Ranked by Revenue (2024)
4.7.2 United States Losartan Potassium and Hydrochlorothiazide Tablet Revenue by Players (2018-2023)
4.7.3 United States Losartan Potassium and Hydrochlorothiazide Tablet Sales by Players (2018-2023)
5 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Region
5.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size in Volume by Region (2018-2034)
5.2.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Region: 2018-2023
5.2.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Forecast by Region (2024-2034)
5.3 Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size in Value by Region (2018-2034)
5.3.1 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Region: 2018-2023
5.3.2 Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Losartan Potassium and Hydrochlorothiazide Tablet Market Size YoY Growth 2018-2034
6.2 Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
6.3 Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Losartan Potassium and Hydrochlorothiazide Tablet Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Market Size YoY Growth 2018-2034
7.2 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
7.3 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Losartan Potassium and Hydrochlorothiazide Tablet Market Size YoY Growth 2018-2034
8.2 China Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
8.3 China Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Losartan Potassium and Hydrochlorothiazide Tablet Market Size YoY Growth 2018-2034
9.2 APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Potassium Content of Losartan Per Tablet (2018, 2024 & 2034)
9.3 APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Losartan Potassium and Hydrochlorothiazide Tablet Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Cozaar
10.1.1 Cozaar Company Information
10.1.2 Cozaar Description and Business Overview
10.1.3 Cozaar Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cozaar Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.1.5 Cozaar Recent Development
10.2 Lepu Medical Technology (Beijing)
10.2.1 Lepu Medical Technology (Beijing) Company Information
10.2.2 Lepu Medical Technology (Beijing) Description and Business Overview
10.2.3 Lepu Medical Technology (Beijing) Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lepu Medical Technology (Beijing) Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.2.5 Lepu Medical Technology (Beijing) Recent Development
10.3 Zhejiang NuoDe Pharmaceutical
10.3.1 Zhejiang NuoDe Pharmaceutical Company Information
10.3.2 Zhejiang NuoDe Pharmaceutical Description and Business Overview
10.3.3 Zhejiang NuoDe Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zhejiang NuoDe Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.3.5 Zhejiang NuoDe Pharmaceutical Recent Development
10.4 Dawnrays Pharmaceutical
10.4.1 Dawnrays Pharmaceutical Company Information
10.4.2 Dawnrays Pharmaceutical Description and Business Overview
10.4.3 Dawnrays Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Dawnrays Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.4.5 Dawnrays Pharmaceutical Recent Development
10.5 TIANJIN PHARMACEUTICAL DA REN TANG GROUP
10.5.1 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Company Information
10.5.2 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Description and Business Overview
10.5.3 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.5.4 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.5.5 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Recent Development
10.6 Beijing Winsunny Pharmaceutical
10.6.1 Beijing Winsunny Pharmaceutical Company Information
10.6.2 Beijing Winsunny Pharmaceutical Description and Business Overview
10.6.3 Beijing Winsunny Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Beijing Winsunny Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.6.5 Beijing Winsunny Pharmaceutical Recent Development
10.7 Shandong XinYi Pharmaceutical
10.7.1 Shandong XinYi Pharmaceutical Company Information
10.7.2 Shandong XinYi Pharmaceutical Description and Business Overview
10.7.3 Shandong XinYi Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shandong XinYi Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.7.5 Shandong XinYi Pharmaceutical Recent Development
10.8 Zhejiang Huahai Pharmaceutical
10.8.1 Zhejiang Huahai Pharmaceutical Company Information
10.8.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
10.8.3 Zhejiang Huahai Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zhejiang Huahai Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.8.5 Zhejiang Huahai Pharmaceutical Recent Development
10.9 Beijing Twinluck
10.9.1 Beijing Twinluck Company Information
10.9.2 Beijing Twinluck Description and Business Overview
10.9.3 Beijing Twinluck Losartan Potassium and Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beijing Twinluck Losartan Potassium and Hydrochlorothiazide Tablet Products Offered
10.9.5 Beijing Twinluck Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Losartan Potassium and Hydrochlorothiazide Tablet Industry Chain Analysis
11.2 Losartan Potassium and Hydrochlorothiazide Tablet Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Losartan Potassium and Hydrochlorothiazide Tablet Production Mode & Process
11.4 Losartan Potassium and Hydrochlorothiazide Tablet Sales and Marketing
11.4.1 Losartan Potassium and Hydrochlorothiazide Tablet Sales Channels
11.4.2 Losartan Potassium and Hydrochlorothiazide Tablet Distributors
11.5 Losartan Potassium and Hydrochlorothiazide Tablet Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Losartan Potassium and Hydrochlorothiazide Tablet CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Losartan Potassium and Hydrochlorothiazide Tablet Market Trends
Table 3. Losartan Potassium and Hydrochlorothiazide Tablet Market Drivers
Table 4. Losartan Potassium and Hydrochlorothiazide Tablet Market Challenges
Table 5. Losartan Potassium and Hydrochlorothiazide Tablet Market Restraints
Table 6. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Growth Rate (CAGR) by Potassium Content of Losartan Per Tablet: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Growth Rate (CAGR) by Potassium Content of Losartan Per Tablet: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Losartan Potassium and Hydrochlorothiazide Tablet Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Losartan Potassium and Hydrochlorothiazide Tablet Revenue Share by Manufacturer, 2018-2023
Table 13. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Share by Manufacturer, 2018-2023
Table 15. Global Losartan Potassium and Hydrochlorothiazide Tablet Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Losartan Potassium and Hydrochlorothiazide Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Losartan Potassium and Hydrochlorothiazide Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Losartan Potassium and Hydrochlorothiazide Tablet as of 2024)
Table 18. Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Product Offered and Application
Table 20. Global Key Manufacturers of Losartan Potassium and Hydrochlorothiazide Tablet, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Losartan Potassium and Hydrochlorothiazide Tablet in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Losartan Potassium and Hydrochlorothiazide Tablet Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Losartan Potassium and Hydrochlorothiazide Tablet Revenue Share by Players, (2018-2023)
Table 25. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales by Players, (K Units), (2018-2023)
Table 26. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Share by Players, (2018-2023)
Table 27. Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Losartan Potassium and Hydrochlorothiazide Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Losartan Potassium and Hydrochlorothiazide Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Cozaar Company Information
Table 48. Cozaar Description and Business Overview
Table 49. Cozaar Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Cozaar Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 51. Cozaar Recent Development
Table 52. Lepu Medical Technology (Beijing) Company Information
Table 53. Lepu Medical Technology (Beijing) Description and Business Overview
Table 54. Lepu Medical Technology (Beijing) Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Lepu Medical Technology (Beijing) Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 56. Lepu Medical Technology (Beijing) Recent Development
Table 57. Zhejiang NuoDe Pharmaceutical Company Information
Table 58. Zhejiang NuoDe Pharmaceutical Description and Business Overview
Table 59. Zhejiang NuoDe Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Zhejiang NuoDe Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 61. Zhejiang NuoDe Pharmaceutical Recent Development
Table 62. Dawnrays Pharmaceutical Company Information
Table 63. Dawnrays Pharmaceutical Description and Business Overview
Table 64. Dawnrays Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Dawnrays Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 66. Dawnrays Pharmaceutical Recent Development
Table 67. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Company Information
Table 68. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Description and Business Overview
Table 69. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 71. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Recent Development
Table 72. Beijing Winsunny Pharmaceutical Company Information
Table 73. Beijing Winsunny Pharmaceutical Description and Business Overview
Table 74. Beijing Winsunny Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Beijing Winsunny Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 76. Beijing Winsunny Pharmaceutical Recent Development
Table 77. Shandong XinYi Pharmaceutical Company Information
Table 78. Shandong XinYi Pharmaceutical Description and Business Overview
Table 79. Shandong XinYi Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Shandong XinYi Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 81. Shandong XinYi Pharmaceutical Recent Development
Table 82. Zhejiang Huahai Pharmaceutical Company Information
Table 83. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 84. Zhejiang Huahai Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Zhejiang Huahai Pharmaceutical Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 86. Zhejiang Huahai Pharmaceutical Recent Development
Table 87. Beijing Twinluck Company Information
Table 88. Beijing Twinluck Description and Business Overview
Table 89. Beijing Twinluck Losartan Potassium and Hydrochlorothiazide Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Beijing Twinluck Losartan Potassium and Hydrochlorothiazide Tablet Product
Table 91. Beijing Twinluck Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Losartan Potassium and Hydrochlorothiazide Tablet Customers List
Table 95. Losartan Potassium and Hydrochlorothiazide Tablet Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Losartan Potassium and Hydrochlorothiazide Tablet Product Picture
Figure 2. Global Losartan Potassium and Hydrochlorothiazide Tablet Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Losartan Potassium and Hydrochlorothiazide Tablet Market Size 2018-2034 (US$ Million)
Figure 4. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales 2018-2034 (K Units)
Figure 5. United States Losartan Potassium and Hydrochlorothiazide Tablet Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Losartan Potassium and Hydrochlorothiazide Tablet Market Size 2018-2034 (US$ Million)
Figure 7. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales 2018-2034 (K Units)
Figure 8. United States Losartan Potassium and Hydrochlorothiazide Tablet Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Losartan Potassium and Hydrochlorothiazide Tablet Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Losartan Potassium and Hydrochlorothiazide Tablet Report Years Considered
Figure 11. Product Picture of 50mg
Figure 12. Product Picture of 100mg
Figure 13. Product Picture of Others
Figure 14. Global Losartan Potassium and Hydrochlorothiazide Tablet Market Share by Potassium Content of Losartan Per Tablet in 2024 & 2034
Figure 15. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Potassium Content of Losartan Per Tablet (2018-2034) & (US$ Million)
Figure 16. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Value by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 17. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 18. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 19. Global Losartan Potassium and Hydrochlorothiazide Tablet Price by Potassium Content of Losartan Per Tablet (2018-2034) & (US$/Unit)
Figure 20. United States Losartan Potassium and Hydrochlorothiazide Tablet Market Share by Potassium Content of Losartan Per Tablet in 2024 & 2034
Figure 21. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Potassium Content of Losartan Per Tablet (2018-2034) & (US$ Million)
Figure 22. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Value by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 23. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 24. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 25. United States Losartan Potassium and Hydrochlorothiazide Tablet Price by Potassium Content of Losartan Per Tablet (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Children
Figure 27. Product Picture of Adult
Figure 28. Product Picture of Elderly
Figure 29. Global Losartan Potassium and Hydrochlorothiazide Tablet Market Share by Application in 2024 & 2034
Figure 30. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Application (2018-2034) & (US$ Million)
Figure 31. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Value by Application (2018-2034)
Figure 32. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 33. Global Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 34. Global Losartan Potassium and Hydrochlorothiazide Tablet Price by Application (2018-2034) & (US$/Unit)
Figure 35. United States Losartan Potassium and Hydrochlorothiazide Tablet Market Share by Application in 2024 & 2034
Figure 36. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value by Application (2018-2034) & (US$ Million)
Figure 37. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Value by Application (2018-2034)
Figure 38. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 39. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 40. United States Losartan Potassium and Hydrochlorothiazide Tablet Price by Application (2018-2034) & (US$/Unit)
Figure 41. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 42. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 43. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 44. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 45. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 46. Americas Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 47. United States Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Canada Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Mexico Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 52. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 53. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 54. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 55. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 56. EMEA Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 57. Europe Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Africa Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. China Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 61. China Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 62. China Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 63. China Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 64. China Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 65. China Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 66. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 67. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 68. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales by Potassium Content of Losartan Per Tablet (2018-2034) & (K Units)
Figure 69. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Potassium Content of Losartan Per Tablet (2018-2034)
Figure 70. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales by Application (2018-2034) & (K Units)
Figure 71. APAC Losartan Potassium and Hydrochlorothiazide Tablet Sales Market Share in Volume by Application (2018-2034)
Figure 72. Japan Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. South Korea Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. China Taiwan Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. India Losartan Potassium and Hydrochlorothiazide Tablet Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Losartan Potassium and Hydrochlorothiazide Tablet Value Chain
Figure 78. Losartan Potassium and Hydrochlorothiazide Tablet Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed